Stock listing

Frankfurt:KH6 NewAmsterdam Pharma Company N.V. Aktie

German listing (Frankfurt) of NewAmsterdam Pharma Company N.V. · home listing NASDAQ:NAMS

Follow NewAmsterdam Pharma Company N.V. into a list and get an email when it puts out news.

Share price · FWB:KH6

€17.09 EUR -0.64 (-3.6%)

Close on Nov 17, 2026

Past year -44.2% · daily closes, Nov 17, 2025 – Nov 5, 2026, adjusted for splits
Day range
€16.81 – €17.09 EURNov 17, 2026
Market cap
€2.00B EURAt the close on Nov 17, 2026 · price × 116.9M shares outstanding
52-week range
€16.56 – €35.28 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
Traded on an average day
€2,346 EURMedian day 0 shares · 35 days with no trades · last 3 months, Aug 17, 2026 – Nov 5, 2026
NewAmsterdam Pharma Company N.V. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:NAMS · Home$19.39 USD-0.07 (-0.4%)1,364,084$19.45$20.30$18.90$19.46Close on Nov 17, 2026
Dusseldorf:KH6€17.46 EUR-0.215 (-1.2%)—€17.33€17.46€17.27€17.67Close on Nov 17, 2026
Frankfurt:KH6€17.09 EUR-0.645 (-3.6%)—€16.81€17.09€16.81€17.74Close on Nov 17, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 5, 2026 · FWB:KH6 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€17.86-1.198-6.3%€17.81€18.00€17.77105
€19.06+2.181+12.9%€16.94€19.11€16.79105
€16.88-0.685-3.9%€16.71€16.88€16.560
€17.57-0.64-3.5%€17.57€17.57€17.570
€18.21-0.375-2.0%€18.12€18.21€18.1074
€18.58+0.985+5.6%€18.47€18.60€18.35590
€17.60+0.671+4.0%€17.84€18.02€17.3730
€16.92+0.112+0.7%€16.94€16.94€16.920
€16.81-1.62-8.8%€17.30€17.30€16.71126
€18.43-0.127-0.7%€18.35€18.48€18.321,042
€18.56-0.067-0.4%€18.26€18.61€18.070
€18.63+1.154+6.6%€18.34€18.64€18.120
€17.47+0.672+4.0%€17.47€17.47€17.470
€16.80-0.679-3.9%€16.79€16.81€16.770
€17.48+0.147+0.8%€17.44€17.48€17.410
€17.33-0.392-2.2%€16.99€17.40€16.910
€17.72-0.574-3.1%€17.29€17.73€17.240
€18.30-0.263-1.4%€18.22€18.39€18.200
€18.56-0.169-0.9%€18.47€18.65€18.450
€18.73-0.228-1.2%€17.92€18.83€17.92440
€18.96+0.022+0.1%€18.96€18.96€18.96500
€18.94-0.753-3.8%€19.03€19.07€18.850
€19.69-1.33-6.3%€19.34€19.74€19.100
€21.02+0.519+2.5%€19.78€21.22€19.62100
€20.50-0.52-2.5%€21.20€21.41€20.44218
€21.02+1.064+5.3%€22.33€22.46€20.92350
€19.96-0.489-2.4%€19.95€20.03€19.93300
€20.45+1.243+6.5%€19.89€20.47€19.710
€19.20-0.266-1.4%€20.76€21.05€18.8085
€19.47+0.434+2.3%€19.14€19.54€19.1194
€19.03-0.731-3.7%€19.00€19.13€19.000
€19.77+0.35+1.8%€19.52€19.77€19.360
€19.42-1.091-5.3%€18.90€19.47€18.870
€20.51+1.891+10.2%€20.52€20.60€19.5468
€18.62-1.01-5.1%€18.16€18.67€18.13200
€19.63+1.106+6.0%€17.63€19.64€17.42541
€18.52-0.105-0.6%€17.43€18.53€17.24192
€18.62-0.274-1.4%€18.54€18.68€18.5354
€18.90+0.177+0.9%€18.87€18.99€18.85270
€18.72-0.331-1.7%€18.07€18.76€18.061,406
€19.05-2.069-9.8%€19.05€19.05€19.050
€21.12-0.646-3.0%€21.11€21.15€21.100
€21.77+0.306+1.4%€21.77€21.77€21.770
€21.46+0.069+0.3%€21.46€21.46€21.460
€21.39-0.161-0.7%€21.33€21.39€21.130
€21.55+0.568+2.7%€21.14€21.72€21.090
€20.99+0.255+1.2%€20.65€21.08€20.650
€20.73-1.033-4.7%€20.92€20.96€20.730
€21.76-0.652-2.9%€21.32€21.84€21.020
€22.42-0.665-2.9%€22.05€22.70€22.01252
€23.08+0.539+2.4%€22.53€23.36€22.390
€22.54+0.121+0.5%€22.30€22.62€22.250
€22.42-0.639-2.8%€22.02€22.59€21.790
€23.06-0.083-0.4%€22.76€23.32€22.740
€23.14-0.524-2.2%€22.79€23.24€22.7682
€23.67+0.471+2.0%€23.28€23.70€23.260
€23.20+0.822+3.7%€22.24€23.47€22.210
€22.37+0.019+0.1%€22.23€22.40€22.100
€22.35+0.0090.0%€22.22€22.42€22.140
Ticker
Frankfurt:KH6
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • NewAmsterdam Pharma (NASDAQ:NAMS) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 9:00 AM ET

    Watch Transcript
  • NewAmsterdam Pharma (NASDAQ:NAMS) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

All NewAmsterdam Pharma Company N.V. news

Financings

  • Public offering of ordinary shares and pre-funded warrants

    Dec 11, 2024

    Made bigger: about US$416.5M · US$24.5 a share · Jefferies +5

    Dealers: Jefferies (co-lead), Goldman Sachs & Co. (co-lead), Leerink Partners (co-lead), TD Cowen (co-lead), Guggenheim Securities (co-lead), William Blair (co-lead)

    Announced Dec 10, 2024 · Made bigger Dec 11, 2024

Read by 6ix AI from the company's releases

Decks

NewAmsterdam Pharma Company N.V. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
20 in the last 12 months · 93 in all · newest Nov 6, 2026 · oldest 2022
Calls
2 calls with a replay · 2 with a transcript · latest Aug 5, 2026
Decks
33 decks · latest Nov 4, 2026

Where NewAmsterdam Pharma Company N.V. is listed

ListingExchangeCountryCurrency
NASDAQ:NAMS · Home listingNASDAQUnited StatesUSD
gettex:KH6gettexGermanyEUR
LS Exchange:A3DUACLS ExchangeGermanyEUR
Tradegate:KH6TradegateGermanyEUR
BOATS:NAMSBOATSUnited StatesUSD
Lang & Schwarz:A3DUACLang & SchwarzGermanyEUR
Dusseldorf:KH6DusseldorfGermanyEUR
Frankfurt:KH6 · This pageFrankfurtGermanyEUR
Hamburg:KH6HamburgGermanyEUR
Munich:KH6MunichGermanyEUR
Stuttgart:KH6StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about NewAmsterdam Pharma Company N.V.